Loading
Latest filing published 24 Sept 2026 for Skye Bioscience, Inc., €40k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
5AM Partners VII, LLC is a declared insider of Skye Bioscience, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 31 January 2024 to 23 September 2026, the count stands at 19 filings.
Market trades split into 2 purchases (€15.2M) and 17 sales (€1.9M). Taken together, the purchases exceed the sales by €13.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: no purchases and 15 sales on the market.
On 24 September 2026 came the latest disclosure, an open-market sale for €40k in Skye Bioscience, Inc. The last insider purchase was made public on 15 March 2024, 947 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Same trade as the filing by Andrew J. Schwab, counted once · View ↗
19 of 18 declarations